[1]
Phansenee, S., Angkatavanich, T., Rittiluechai, K. and Intharaburan, S. 2024. Incidence of Cardiotoxicity Associated with The Use of Pegylated Liposomal Doxorubicin in Gynecologic Malignancies. Biomedical Sciences and Clinical Medicine. 63, 4 (Oct. 2024), 229–233.